LIFESTANCE HEALTH GROUP INC (LFST) — insider trading
Health Care · NASDAQ
LIFESTANCE HEALTH GROUP INC (LFST) has 37 reported SEC Form 4 insider transactions in our data, including 23 open-market sales among the most recent 37 (latest 2026-09-22).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-22 | Bourdon David | Director, Officer (Chief Executive Officer) | Bona fide gift | 150,000 | — | $0 | Form 4 |
| 2026-09-22 | Bourdon David | Director, Officer (Chief Executive Officer) | Bona fide gift | 150,000 | — | $0 | Form 4 |
| 2026-09-22 | Bourdon David | Director, Officer (Chief Executive Officer) | Bona fide gift | 150,000 | — | $0 | Form 4 |
| 2026-09-22 | Bourdon David | Director, Officer (Chief Executive Officer) | Bona fide gift | 150,000 | — | $0 | Form 4 |
| 2026-09-11 | TPG GP A, LLC; COULTER JAMES G; WINKELRIED JON | 10% owner | Open-market sale | 18,409,705 | $12.29 | $226.26M | Form 4 |
| 2026-09-02 | Paunovich Vukasin | Officer (Chief Technology Officer) | Open-market sale | 42,067 | $12.87 | $541.4K | Form 4 |
| 2026-09-02 | Bourdon David | Director, Officer (Chief Executive Officer) | Other acquisition or disposition | 150,000 | — | $0 | Form 4 |
| 2026-08-24 | Varanakis Ann | Officer (Chief People Officer) | Shares withheld for taxes / exercise cost | 8,156 | $12.16 | $99.2K | Form 4 |
| 2026-08-14 | DeLuca Teresa | Director | Open-market sale | 7,500 | $12.68 | $95.1K | Form 4 |
| 2026-08-13 | DeLuca Teresa | Director | Open-market sale | 20,441 | $12.23 | $250.0K | Form 4 |
| 2026-08-11 | Burdick Kenneth A | Director | Open-market sale | 500,000 | $11.51 | $5.75M | Form 4 |
| 2026-08-10 | Miller Lisa K | Officer (Chief Operating Officer) | Open-market sale | 47,912 | $10.85 | $519.8K | Form 4 |
| 2026-08-10 | TPG GP A, LLC; COULTER JAMES G; WINKELRIED JON | 10% owner | Open-market sale | 13,643,207 | $10.62 | $144.89M | Form 4 |
| 2026-08-10 | Paunovich Vukasin | Officer (Chief Technology Officer) | Open-market sale | 44,394 | $10.85 | $481.7K | Form 4 |
| 2026-07-06 | Burdick Kenneth A | Director | Grant / award / vesting | 45,495 | — | $0 | Form 4 |
| 2026-07-02 | Goltermann Lori | Director | Grant / award / vesting | 35,492 | — | $0 | Form 4 |
| 2026-07-02 | Justice Thurman | Director | Grant / award / vesting | 35,492 | — | $0 | Form 4 |
| 2026-07-02 | DeLuca Teresa | Director | Grant / award / vesting | 17,746 | — | $0 | Form 4 |
| 2026-07-02 | Personette Sarah | Director | Grant / award / vesting | 17,746 | — | $0 | Form 4 |
| 2026-07-02 | Bessler Robert | Director | Grant / award / vesting | 17,746 | — | $0 | Form 4 |
| 2026-07-02 | Palmer Eric P | Director | Grant / award / vesting | 17,746 | — | $0 | Form 4 |
| 2026-06-26 | Bessler Robert | Director | Open-market sale | 447,169 | $10.13 | $4.53M | Form 4 |
| 2026-06-26 | Bessler Robert | Director | Open-market sale | 447,168 | $10.13 | $4.53M | Form 4 |
| 2026-06-11 | Paunovich Vukasin | Officer (Chief Technology Officer) | Shares withheld for taxes / exercise cost | 17,456 | $8.61 | $150.3K | Form 4 |
| 2026-05-12 | TPG GP A, LLC; COULTER JAMES G; WINKELRIED JON | 10% owner | Open-market sale | 28,281,943 | $8.02 | $226.82M | Form 4 |
| 2026-05-12 | BLACK DARREN M. | Director | Open-market sale | 5,899,661 | $8.02 | $47.32M | Form 4 |
| 2026-05-12 | Shuey Eric | Director | Open-market sale | 243,362 | $8.02 | $1.95M | Form 4 |
| 2026-05-12 | Bessler Robert | Director | Open-market sale | 287,517 | $8.02 | $2.31M | Form 4 |
| 2026-05-12 | Bessler Robert | Director | Open-market sale | 287,517 | $8.02 | $2.31M | Form 4 |
| 2026-05-07 | Bessler Robert | Director | Open-market sale | 37,500 | $8.55 | $320.6K | Form 4 |
| 2026-05-07 | Bessler Robert | Director | Open-market sale | 37,500 | $8.55 | $320.6K | Form 4 |
| 2026-04-24 | Bessler Robert | Director | Open-market sale | 31,074 | $7.05 | $219.1K | Form 4 |
| 2026-04-24 | Bessler Robert | Director | Open-market sale | 31,073 | $7.05 | $219.1K | Form 4 |
| 2026-04-23 | Bessler Robert | Director | Open-market sale | 3,876 | $7.00 | $27.1K | Form 4 |
| 2026-04-23 | Bessler Robert | Director | Open-market sale | 3,876 | $7.00 | $27.1K | Form 4 |
| 2026-04-21 | Bessler Robert | Director | Open-market sale | 2,550 | $7.01 | $17.9K | Form 4 |
| 2026-04-21 | Bessler Robert | Director | Open-market sale | 2,551 | $7.01 | $17.9K | Form 4 |
Ask the chat about LFST's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: LIFESTANCE HEALTH GROUP INC (LFST).
Last updated 2026-09-22 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.